Ameritas Investment Partners, Inc. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 75 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$19,000
-54.8%
3,9380.0%0.00%
-50.0%
Q4 2019$42,000
+27.3%
3,938
+24.9%
0.00%0.0%
Q3 2019$33,000
-31.2%
3,1530.0%0.00%0.0%
Q2 2019$48,000
+17.1%
3,1530.0%0.00%0.0%
Q1 2019$41,000
+127.8%
3,153
+63.4%
0.00%
+100.0%
Q4 2018$18,000
-43.8%
1,9300.0%0.00%0.0%
Q3 2018$32,000
+3.2%
1,9300.0%0.00%0.0%
Q2 2018$31,000
+3.3%
1,9300.0%0.00%0.0%
Q1 2018$30,0000.0%1,9300.0%0.00%0.0%
Q4 2017$30,000
+172.7%
1,930
+47.0%
0.00%0.0%
Q3 2017$11,000
-8.3%
1,3130.0%0.00%0.0%
Q2 2017$12,000
+9.1%
1,3130.0%0.00%0.0%
Q1 2017$11,0001,3130.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders